Androgen-induced regrowth in the castrated rat ventral prostate: Role of 5α-reductase

Endocrinology

Volumn 140, Issue 10, 1999, Pages 4509-4515

  Wright, A S ^a   Douglas, R C ^a   Thomas, L N ^a   Lazier, C B ^a   Rittmaster, R S ^a  

^a DALHOUSIE UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; ANDROSTANOLONE; FINASTERIDE; STEROID 5ALPHA REDUCTASE; STEROID 5ALPHA REDUCTASE INHIBITOR; TESTOSTERONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CASTRATION; DNA CONTENT; DOSE RESPONSE; HORMONAL REGULATION; HORMONE ACTION; MALE; NONHUMAN; PRIORITY JOURNAL; PROSTATE VENTRAL LOBE; RAT; REGENERATION; TESTOSTERONE BLOOD LEVEL; WEIGHT;

EID: 0033305674     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.140.10.7039     Document Type: Article

References (36)

1. The conversion of testosterone to 5-α-androstan-17-β-ol-3-one by rat prostate in vivo and in vitro
2. Selective retention of dihydrotestosterone by prostatic nuclei
3. 4-MAPC, a 5α-reductase inhibitor, reduces rat ventral prostate weight, DNA and prostatein concentrations
4. Effects of 4-MAPC, a 5 α-reductase inhibitor, and cyproterone acetate on regrowth of the rat ventral prostate
5. Pharmacological induction of 5 α-reductase deficiency in the rat: Separation of testosterone-mediated and 5 α-dihydrotestosterone-mediated effects
6. Prostatic involution in rats induced by a novel 5 α-reductase inhibitor, SK and F 105657: Role for testosterone in the androgenic response
7. Effects of finasteride on the rat ventral prostate
8. Feed-forward control of prostate growth: Dihydrotestosterone induces expression of its own biosynthetic enzyme, steroid 5 α-reductase
9. The effect of 4MA, a potent inhibitor of 5 α-reductase, on the growth of androgen-responsive human genitourinary tumors grown in athymic nude mice
10. Effect of early treatment of prostate cancer with the 5 α-reductase inhibitor turosteride in Dunning R3327 prostatic carcinoma in rats
11. Responses of LNCaP prostatic adenocarcinoma cell cultures to LY300502, a benzoquinolinone human type I 5 α-reductase inhibitor
12. Finasteride dose-dependently reduces the proliferation rate of the LNCaP human prostatic cancer cell line in vitro
13. Evidence for atrophy and apoptosis in the ventral prostate of rats given the 5 α-reductase inhibitor finasteride
14. Relative potency of testosterone and dihydrotestosterone in preventing atrophy and apoptosis in the prostate of the castrated rat
15. The mechanism of androgen uptake and concentration by rat ventral prostate in organ culture
16. Dihydrotestosterone does not induce prostate adenocarcinoma in L-W rats
17. Dihydrotestosterone prevents spontaneous adenocarcinomas in the prostate-seminal vesicle in aging L-W rats
18. Transdermal dihydrotestosterone treatment of 'andropause'
19. Androgen metabolism in men receiving finasteride before prostatectomy
20. Determination of DNA concentration with diphenylamine
21. Differential effect of 5 α-reductase inhibition and castration on androgen-regulated gene expression in rat prostate
22. Testosterone and 5α-dihydrotestosterone interact differently with the androgen receptor to enhance transcription of the MMTV-CAT reporter gene
23. Testosterone at high concentrations interacts with the human androgen receptor similarly to dihydrotestosterone
24. Metabolism of 5 α-reduced androgens by various tissues of the male rat
25. 3 α-Hydroxysteroid oxidoreductase activities in dihydrotestosterone degradation and back-formation in rat prostate and epididymis
26. Quantal relationship between prostatic dihydrotestosterone and prostatic cell content: Critical threshold concept
27. Specificity of ligand-dependent androgen receptor stabilization: Receptor domain interactions influence ligand dissociation and receptor stability
28. Molecular basis of agonism and antagonism in the oestrogen receptor
29. Cloning and characterization of TDD5, an androgen target gene that is differentially repressed by testosterone and dihydrotestosterone
30. Identification of genes expressed in the rat prostate that are modulated differently by castration and finasteride treatment
31. Developmental and physiological effects of estrogen receptor gene disruption in mice
32. Aromatase deficiency in male and female siblings caused by a novel mutation and the physiological role of estrogens
33. Effect of testosterone and estradiol in a man with aromatase deficiency
34. Estrogen resistance caused by a mutation in the estrogen-receptor gene in a man
35. Steroid 5 α-reductase: Two genes/two enzymes
36. Relative binding affinity of anabolic-androgenic steroids: Comparison of the binding to the androgen receptors in skeletal muscle and in prostate, as well as to sex hormone-binding globulin